These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8583569)

  • 21. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
    Vachtenheim J; Horáková I; Novotná H
    Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
    Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
    Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ha-ras-1 alleles in Norwegian lung cancer patients.
    Ryberg D; Tefre T; Ovrebø S; Skaug V; Stangeland L; Naalsund A; Baera R; Børresen AL; Haugen A
    Hum Genet; 1990 Nov; 86(1):40-4. PubMed ID: 1979305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.
    Mo L; Zheng X; Huang HY; Shapiro E; Lepor H; Cordon-Cardo C; Sun TT; Wu XR
    J Clin Invest; 2007 Feb; 117(2):314-25. PubMed ID: 17256055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.
    Gerhard DS; Dracopoli NC; Bale SJ; Houghton AN; Watkins P; Payne CE; Greene MH; Housman DE
    Nature; 1987 Jan 1-7; 325(6099):73-5. PubMed ID: 2879249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
    Shan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
    Ogata N; Kamimura T; Asakura H
    Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
    Ishikawa J; Maeda S; Kamidono S; Sugiyama T
    Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
    Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
    Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.
    Amasyali AS; Kucukgergin C; Erdem S; Sanli O; Seckin S; Nane I
    J Urol; 2012 Dec; 188(6):2398-403. PubMed ID: 23088972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients.
    Lidereau R; Escot C; Theillet C; Champeme MH; Brunet M; Gest J; Callahan R
    J Natl Cancer Inst; 1986 Sep; 77(3):697-701. PubMed ID: 3462411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer.
    Johne A; Roots I; Brockmöller J
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):68-70. PubMed ID: 12540507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.
    Koed K; Wiuf C; Christensen LL; Wikman FP; Zieger K; Møller K; von der Maase H; Orntoft TF
    Cancer Res; 2005 Jan; 65(1):34-45. PubMed ID: 15665277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.
    Saranath D; Bhoite LT; Mehta AR; Sanghavi V; Deo MG
    J Cancer Res Clin Oncol; 1991; 117(5):484-8. PubMed ID: 1679760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
    Dalbagni G; Presti JC; Reuter VE; Zhang ZF; Sarkis AS; Fair WR; Cordon-Cardo C
    Diagn Mol Pathol; 1993 Mar; 2(1):4-13. PubMed ID: 7904525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.